BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 12354999)

  • 1. Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver.
    Arbab AS; Ichikawa T; Sou H; Araki T; Nakajima H; Ishigame K; Yoshikawa T; Kumagai H
    Radiology; 2002 Oct; 225(1):151-8. PubMed ID: 12354999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.
    Pauleit D; Textor J; Bachmann R; Conrad R; Flacke S; Layer G; Kreft B; Schild H
    Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM; Kim CS; Youk JH; Lee MS
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners.
    Limanond P; Raman SS; Sayre J; Lu DS
    J Magn Reson Imaging; 2004 Oct; 20(4):640-7. PubMed ID: 15390231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hepatic tumor detection with ferumoxides-enhanced MR imaging with a 1.5-T system: comparison of four imaging pulse sequences.
    Kanematsu M; Itoh K; Matsuo M; Maetani Y; Ametani F; Kondo H; Kato H; Hoshi H
    J Magn Reson Imaging; 2001 Feb; 13(2):249-57. PubMed ID: 11169831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging.
    Mori K; Scheidler J; Helmberger T; Holzknecht N; Schauer R; Schirren CA; Bittmann I; Dugas M; Reiser M
    AJR Am J Roentgenol; 2002 Oct; 179(4):1045-51. PubMed ID: 12239063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging.
    Van Beers BE; Lacrosse M; Jamart J; Grandin C; Gigot JF; Horsmans Y; Demeure R; Pringot J
    AJR Am J Roentgenol; 1997 Mar; 168(3):713-7. PubMed ID: 9057521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of malignant hepatic tumors with ferumoxides-enhanced MRI: comparison of five gradient-recalled echo sequences with different TEs.
    Matsuo M; Kanematsu M; Itoh K; Murakami T; Maetani Y; Kondo H; Goshima S; Kako N; Hoshi H; Konishi J; Moriyama N; Nakamura H
    AJR Am J Roentgenol; 2004 Jan; 182(1):235-42. PubMed ID: 14684545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging.
    Paley MR; Mergo PJ; Torres GM; Ros PR
    AJR Am J Roentgenol; 2000 Jul; 175(1):159-63. PubMed ID: 10882267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic MR imaging using ferumoxides: prospective evaluation with surgical and intraoperative sonographic confirmation in 25 cases.
    Raman SS; Lu DS; Chen SC; Sayre J; Eilber F; Economou J
    AJR Am J Roentgenol; 2001 Oct; 177(4):807-12. PubMed ID: 11566677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal liver lesions: characterization with conventional spin-echo versus fast spin-echo T2-weighted MR imaging.
    Schima W; Saini S; Echeverri JA; Hahn PF; Harisinghani M; Mueller PR
    Radiology; 1997 Feb; 202(2):389-93. PubMed ID: 9015063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions.
    Kumano S; Murakami T; Kim T; Hori M; Okada A; Sugiura T; Noguchi Y; Kawata S; Tomoda K; Nakamura H
    AJR Am J Roentgenol; 2003 Nov; 181(5):1335-9. PubMed ID: 14573430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis between metastatic tumors and nonsolid benign lesions of the liver using ferucarbotran-enhanced MR imaging.
    Higashihara H; Murakami T; Kim T; Hori M; Onishi H; Nakata S; Osuga K; Tomoda K; Nakamura H
    Eur J Radiol; 2010 Jan; 73(1):125-30. PubMed ID: 19019608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography.
    Senéterre E; Taourel P; Bouvier Y; Pradel J; Van Beers B; Daures JP; Pringot J; Mathieu D; Bruel JM
    Radiology; 1996 Sep; 200(3):785-92. PubMed ID: 8756932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging.
    Takahama K; Amano Y; Hayashi H; Ishihara M; Kumazaki T
    Abdom Imaging; 2003; 28(4):525-30. PubMed ID: 14580096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations.
    del Frate C; Bazzocchi M; Mortele KJ; Zuiani C; Londero V; Como G; Zanardi R; Ros PR
    Radiology; 2002 Dec; 225(3):766-72. PubMed ID: 12461259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.